Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xe MRI in ILD
NCT06012500Phase 2Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in interstitial lung disease (ILD), sponsored by Cincinnati Children's Hospital Medical Center. Started Apr 2022; status: active, not recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT06012500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06012500.